SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038206
Filing Date
2019-08-07
Accepted
2019-08-07 16:31:40
Documents
74
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526077_10q.htm 10-Q 589519
2 EXHIBIT 10.3 tv526077_ex10-3.htm EX-10.3 978323
3 EXHIBIT 31.1 tv526077_ex31-1.htm EX-31.1 9678
4 EXHIBIT 31.2 tv526077_ex31-2.htm EX-31.2 9941
5 EXHIBIT 32.1 tv526077_ex32-1.htm EX-32.1 4344
6 EXHIBIT 32.2 tv526077_ex32-2.htm EX-32.2 4587
  Complete submission text file 0001144204-19-038206.txt   6792769

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvax-20190630.xml EX-101.INS 1705201
8 XBRL TAXONOMY EXTENSION SCHEMA nvax-20190630.xsd EX-101.SCH 43796
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20190630_cal.xml EX-101.CAL 45625
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20190630_def.xml EX-101.DEF 157434
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20190630_lab.xml EX-101.LAB 365360
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20190630_pre.xml EX-101.PRE 307547
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 191005926
SIC: 2836 Biological Products, (No Diagnostic Substances)